Cochlear Limited (ASX:COH)

Theseus Pharmaceuticals Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 30, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	383.1	513.6	555.5	629.3	609.6	565
Short-Term Investments	-	-	-	-	-	365
Cash & Short-Term Investments	383.1	513.6	555.5	629.3	609.6	930
Cash Growth	-21.04%	-7.54%	-11.73%	3.23%	-34.45%	1083.21%
Accounts Receivable	501.6	425.3	388.4	308.4	262.1	211.4
Other Receivables	12.1	76.7	69.1	82	103.4	93.5
Receivables	513.7	502	457.5	390.4	365.5	304.9
Inventory	461.1	391.6	311.5	270.2	216.1	223.8
Prepaid Expenses	50.3	37.2	33.3	28.7	21.2	17.6
Other Current Assets	2.4	7.7	3.7	8.4	17.6	1.2
Total Current Assets	1,411	1,452	1,362	1,327	1,230	1,478
Property, Plant & Equipment	537.6	517.2	447.2	439.2	428.5	438.8
Long-Term Investments	198.9	181.3	188.1	187.9	226.8	99.9
Goodwill	-	257.7	256.1	257.1	267.3	270.9
Other Intangible Assets	467.8	193.3	188	135.4	81.1	81.3
Long-Term Accounts Receivable	0.4	1.3	0.9	-	-	-
Long-Term Deferred Tax Assets	170.6	138.7	125.3	116.1	152	147.1
Long-Term Deferred Charges	-	-	-	-	37.1	58.1
Other Long-Term Assets	0.2	3.5	1.6	2.4	3.3	2.1
Total Assets	2,786	2,745	2,569	2,465	2,426	2,576
Accounts Payable	285.5	303.2	270.4	232.4	202.9	159.3
Accrued Expenses	123.9	150.5	146.4	101.6	87.9	54.4
Current Portion of Long-Term Debt	-	-	-	42.6	-	393.1
Current Portion of Leases	43.1	41.6	39.2	36.1	31.9	26
Current Income Taxes Payable	35	17.6	17.5	15.2	12.9	7.2
Current Unearned Revenue	74.2	66.7	61.6	54.7	42.8	47
Other Current Liabilities	64.4	51.9	42.9	45	24.1	130.5
Total Current Liabilities	626.1	631.5	578	527.6	402.5	817.5
Long-Term Debt	-	-	-	-	45	79.9
Long-Term Leases	203.5	202.1	162.6	175.2	187.4	205.5
Long-Term Unearned Revenue	8.4	8.6	9.8	7.8	4	2.3
Long-Term Deferred Tax Liabilities	22.6	18.9	18.3	22.4	50.6	14.1
Other Long-Term Liabilities	48.7	35.7	41.5	40	34.9	42.5
Total Liabilities	918.5	904.6	819.9	779.4	736.5	1,174
Common Stock	1,185	1,204	1,250	1,277	1,277	1,272
Retained Earnings	735.5	667.9	555.4	455.3	355.1	116.4
Treasury Stock	-	-	-13.9	-	-	-
Comprehensive Income & Other	-52.9	-31.6	-43	-46.2	57.9	12.7
Shareholders' Equity	1,868	1,841	1,749	1,686	1,690	1,402
Total Liabilities & Equity	2,786	2,745	2,569	2,465	2,426	2,576
Total Debt	246.6	243.7	201.8	253.9	264.3	704.5
Net Cash (Debt)	136.5	269.9	353.7	375.4	345.3	225.5
Net Cash Growth	-50.99%	-23.69%	-5.78%	8.72%	53.13%	-
Net Cash Per Share	2.08	4.11	5.37	5.71	5.25	3.78
Filing Date Shares Outstanding	65.47	65.49	65.61	65.78	65.74	65.69
Total Common Shares Outstanding	65.47	65.49	65.61	65.78	65.74	65.69
Working Capital	784.5	820.6	783.5	799.4	827.5	660
Book Value Per Share	28.53	28.10	26.65	25.63	25.70	21.34
Tangible Book Value	1,400	1,390	1,305	1,293	1,341	1,049
Tangible Book Value Per Share	21.38	21.22	19.88	19.66	20.40	15.97
Land	-	441.2	73.9	75.5	73.1	67.7
Machinery	-	73.8	388.6	347.4	308.3	295.7
Leasehold Improvements	-	84.4	77.6	70.9	66.1	67.6

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.